APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 139 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,447,000 | -91.1% | 30,600 | -93.8% | 0.00% | -90.5% |
| Q3 2021 | $16,203,000 | -58.9% | 491,600 | -21.2% | 0.04% | -59.6% |
| Q2 2021 | $39,430,000 | +33.7% | 623,900 | -9.2% | 0.10% | +28.4% |
| Q1 2021 | $29,496,000 | -27.2% | 687,400 | -3.0% | 0.08% | -25.0% |
| Q4 2020 | $40,532,000 | +65.4% | 708,600 | -12.8% | 0.11% | +54.3% |
| Q3 2020 | $24,504,000 | -18.6% | 812,200 | -11.8% | 0.07% | -20.5% |
| Q2 2020 | $30,086,000 | +28.0% | 921,200 | +5.0% | 0.09% | -2.2% |
| Q1 2020 | $23,500,000 | +195.2% | 877,200 | +237.4% | 0.09% | +400.0% |
| Q4 2019 | $7,961,000 | +367.5% | 260,000 | +267.8% | 0.02% | +350.0% |
| Q3 2019 | $1,703,000 | – | 70,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |